Posterior Reversible Encephalopathy Syndrome
7
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
7 treatments under study, led by Neuroimaging Examinationneurocognitive Testblood Pressureblood Sample
Research Leaders
6 sponsors active, led by Dunjin Chen
Related Conditions
Often studied with 8 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (7)
Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy Syndrome
Prognostic Observation of Posterior Reversible Encephalopathy Syndrome
Inflammatory Biomarkers for the Diagnosis of oPRES
The Predictors of ICU Admission of oPRES
The Clinical and Prognostic Features of PRES
Long-term Consequences of Neuroimaging and Perceived Cognitive Dysfunction in oPRES
Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients
Research Network
Common Treatments
- Neuroimaging Examinationneurocognitive Testblood Pressureblood Sample1
- Whether The Patient Needs To Be Admitted To The Icu1
- Whether The Pe Or E Patient Combined With Pres1
- Blood Copeptin Monitoring1
- No Intervention1
Active Sponsors
- Dunjin Chen4
- Versailles Hospital1
- University Hospital, Tours1
- University of Southern California1
- Yantai Yuhuangding Hospital1
Top Investigators
University Hospital, Tours
Ictal Group
University Hospital, Tours
Related Conditions
- Intensive Care Units1
- Pregnancy Outcomes1
- Neuroimaging1
- Eclampsia1
- Cognitive Dysfunction1